Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lihme Protein Solutions is a Danish private biotechnology company developing and commercializing protein separation and purification technologies for food, healthcare, and biopharma applications. Its core platform, ChimerAds, is a dynamic bed adsorption system designed for selective, high-throughput capture of native and functional proteins from complex raw materials, including industrial side streams, egg, whey, plasma, plant sources, and precision-fermentation broths. The company operates as a B2B technology and process-development partner, offering laboratory development, pilot-scale work, and industrial-scale custom equipment. Lihme Protein Solutions appears to be more of an enabling platform and process technology provider than a therapeutics developer, with activities spanning functional food proteins, bioactive proteins, and bioprocessing applications. Recent commercial activity includes partnerships around egg-derived lysozyme and industrial coproduct valorization, as well as strategic investment support for scale-up.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lihme Protein Solutions.